Cargando…
Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) exhibits high recurrence and mortality rates because of the lack of effective treatment targets. Surgery and traditional chemotherapy are the primary treatment options. Immunotherapy shows high potential for treating various cancers but exhibits limited efficacy...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651025/ https://www.ncbi.nlm.nih.gov/pubmed/36388877 http://dx.doi.org/10.2147/IJN.S388075 |